Radiopharmaceuticals market research report is prepared with detailed statistics and market research insights that results in sharp growth and thriving sustainability in the market for the businesses. Market analysis estimates the expected rise, growth or fall of the product in the specific forecast period. Market definition mentioned in this report covers the market drivers which indicate the factors causing rise in Radiopharmaceuticals market and market restraints which indicates the factors causing fall in the market growth. Moreover, competitive analysis gives an obvious idea about the strategies used by the major competitors in the market which perks up their penetration in the market
“Global Radiopharmaceuticals Market” is predictable to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Download PDF Sample Copy of Report Visit @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market
Major Market Competitors: Global Radiopharmaceuticals Market
Some of the major players operating in the global radiopharmaceuticals market are Cardinal Health Inc., MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging Inc., Bayer AG, Bracco Imaging SpA, Eczacibasi-Monrol Nuclear Products, Nordion Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, CovidienPlc, Positron Corporation, NTP Radioisotopes Pty. Ltd., Advanced Medical Isotope Corporation, Avid Radiopharmaceuticals, Jubilant Pharma, Actinium Pharmaceuticals Inc., AREVA Meds,Immunomedics Inc., Merck& Co., Inc., Navidea, PETNET Solutions Inc., Eckert & Ziegler, Siemens Healthcare, and Positron Corporation among others.
Market Definition: Global Radiopharmaceuticals Market
Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.
Recent trends in the radiopharmaceuticals market such as growing disease which targeted cancer therapy, increasing awareness, expanding applications of molecular imaging, technological advancement, increasing trend of radio-labelled peptides and monoclonal antibodies for the diagnosis and treatment of cancer tumors and increasing use of SPECT & PET scans is expected to drive the market in the forecast period 2017 to 2024.
Radiopharmaceuticals are mostly used for treatment of cancer, bone pain, and thyroid cancer. In the U.S. cancer is second fatal disease whereas in the UK it is the leading cause of death. In most of the third world countries cancer appears much lower. Cancer is the second leading cause of death globally and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. In 2016, an estimated 1.6 million new cases of cancer was diagnosed in the United States and 0.5 million people died from the disease.
On the other hand, shorter half-life of radiopharmaceuticals, stringent regulatory guidelines and competition from conventional diagnostic procedures are some of the factors which may hinder the growth of radiopharmaceuticals market.
Any Specific Requirements? Questions? Ask to Our Industry Expert @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market
Global Radiopharmaceuticals Market, By Type (Diagnostic, Therapeutic), Procedural Volumes (Diagnostic Procedures, Therapeutic Procedures), Application, Sources (Nuclear Reactors, Cyclotrons), End User, Geography (North America, Europe, APAC, South America, MEA)– Industry Trends and Forecast To 2024
table of contents
Chapter 1 Study Coverage
Chapter 2 Executive Summary
Chapter 3 Market Size by Manufacturers
Chapter 4 Production by Regions
Chapter 5 Consumption by Regions
Chapter 6 Market Size by Type
Chapter 7 Market Size by Application
Chapter 8 Manufacturers Profiles
Chapter 9 Production Forecasts
Chapter 10 Consumption Forecast
Chapter 11 Upstream, Industry Chain and Downstream Customers Analysis
Chapter 12 Opportunities & Challenges, Threat and Affecting Factors
Chapter 13 Key Findings
Chapter 14 Appendix
Request for Table of Content of Full Report @ https://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
Radiopharmaceuticals Market report give rising open doors in the market and the future effect of significant drivers and difficulties and, bolster leaders in settling on practical business choices. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities.